Blue Jet Healthcare Limited Net Assets
Blue Jet Healthcare Limited net assets. Based on the latest financial reports, Blue Jet Healthcare Limited (BLUEJET) has net assets worth Rs13.60 Billion INR (≈ $147.07 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs16.41 Billion ≈ $177.49 Million USD) and total liabilities (Rs2.81 Billion ≈ $30.42 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Blue Jet Healthcare Limited (BLUEJET) equity growth momentum to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rs13.60 Billion |
| % of Total Assets | 82.86% |
| Annual Growth Rate | 37.34% |
| 5-Year Change | 160.75% |
| 10-Year Change | N/A |
| Growth Volatility | 16.85 |
Net Assets of Blue Jet Healthcare Limited (2020–2026)
Net assets of Blue Jet Healthcare Limited from 2020 to 2026. This chart illustrates how Blue Jet Healthcare Limited's net assets have evolved over time, based on quarterly financial data. See Blue Jet Healthcare Limited (BLUEJET) net asset quality to measure how much of total assets are equity-financed.
Annual Net Assets for Blue Jet Healthcare Limited (2020–2026)
The table below shows the annual net assets of Blue Jet Healthcare Limited from 2020 to 2026. For live market cap and overall valuation, see BLUEJET market cap overview.
| Year | Net Assets | Change |
|---|---|---|
| 2026-03-31 | Rs13.60 Billion ≈ $147.07 Million |
+20.02% |
| 2025-03-31 | Rs11.33 Billion ≈ $122.54 Million |
+34.06% |
| 2024-03-31 | Rs8.45 Billion ≈ $91.41 Million |
+24.03% |
| 2023-03-31 | Rs6.81 Billion ≈ $73.70 Million |
+30.67% |
| 2022-03-31 | Rs5.22 Billion ≈ $56.40 Million |
+53.48% |
| 2021-03-31 | Rs3.40 Billion ≈ $36.75 Million |
+67.61% |
| 2020-03-31 | Rs2.03 Billion ≈ $21.93 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Blue Jet Healthcare Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Blue Jet Healthcare Limited Net Assets Breakdown (March 2026)
Blue Jet Healthcare Limited net assets breakdown by equity component as of March 2026.
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Rs346.93 Million | 2.55% |
| Other Components | Rs13.25 Billion | 97.45% |
| Total Equity | Rs13.60 Billion | 100.00% |
Blue Jet Healthcare Limited Competitors by Market Cap
The table below lists competitors of Blue Jet Healthcare Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Indo Count Industries Limited
NSE:ICIL
|
$946.93 Million |
|
Shenzhen Shenbao Industrial Co Ltd
SHE:000019
|
$947.15 Million |
|
Beijing Sanyuan Foods Co Ltd
SHG:600429
|
$947.35 Million |
|
TAG Colonia-Immobilien AG
HM:KBU
|
$947.61 Million |
|
Shenzhen Das Intellitech Co Ltd
SHE:002421
|
$946.44 Million |
|
Harbin Gloria Pharmaceuticals
SHE:002437
|
$946.27 Million |
|
Hanmi Financial Corporation
NASDAQ:HAFC
|
$946.11 Million |
|
Healthcare Global Enterprises Limited
NSE:HCG
|
$945.46 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Blue Jet Healthcare Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2025 to 2026, total equity changed from 11,331,110,000 to 13,599,120,000, a change of 2,268,010,000 (20.0%).
- Net income of 2,478,160,000 contributed positively to equity growth.
- Dividend payments of 208,180,000 reduced retained earnings.
Equity Change Factors (2025 to 2026)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rs2.48 Billion | +18.22% |
| Dividends Paid | Rs208.18 Million | -1.53% |
| Other Changes | Rs-1.97 Million | -0.01% |
| Total Change | Rs- | 20.02% |
Book Value vs Market Value Analysis
This analysis compares Blue Jet Healthcare Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 6.43x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 43.45x to 6.43x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-03-31 | Rs11.61 | Rs504.55 | x |
| 2021-03-31 | Rs19.59 | Rs504.55 | x |
| 2022-03-31 | Rs30.07 | Rs504.55 | x |
| 2023-03-31 | Rs39.29 | Rs504.55 | x |
| 2024-03-31 | Rs48.73 | Rs504.55 | x |
| 2025-03-31 | Rs65.31 | Rs504.55 | x |
| 2026-03-31 | Rs78.42 | Rs504.55 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Blue Jet Healthcare Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 18.22%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 26.16%
- • Asset Turnover: 0.58x
- • Equity Multiplier: 1.21x
- Recent ROE (18.22%) is below the historical average (33.64%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 71.91% | 26.91% | 1.43x | 1.86x | Rs1.25 Billion |
| 2021 | 40.73% | 28.01% | 0.92x | 1.58x | Rs1.04 Billion |
| 2022 | 34.82% | 26.83% | 0.95x | 1.37x | Rs1.29 Billion |
| 2023 | 23.48% | 22.27% | 0.83x | 1.26x | Rs918.78 Million |
| 2024 | 19.37% | 23.05% | 0.67x | 1.25x | Rs792.29 Million |
| 2025 | 26.93% | 29.63% | 0.73x | 1.25x | Rs1.92 Billion |
| 2026 | 18.22% | 26.16% | 0.58x | 1.21x | Rs1.12 Billion |
Industry Comparison
This section compares Blue Jet Healthcare Limited's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $4,743,352,000
- Average return on equity (ROE) among peers: 13.60%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Blue Jet Healthcare Limited (BLUEJET) | Rs13.60 Billion | 71.91% | 0.21x | $946.52 Million |
| Concord Biotech Limited (CONCORDBIO) | $9.99 Billion | 23.50% | 0.18x | $1.41 Billion |
| Dishman Carbogen Amcis Limited (DCAL) | $14.52 Billion | 11.78% | 1.05x | $245.89 Million |
| Lyka Labs Limited (LYKALABS) | $682.65 Million | -3.65% | 1.30x | $29.57 Million |
| SMS Lifesciences India Limited (SMSLIFE) | $1.65 Billion | 15.35% | 1.16x | $42.13 Million |
| Supriya Lifescience Limited (SUPRIYA) | $6.16 Billion | 24.66% | 0.19x | $737.48 Million |
| Take Solutions Limited (TAKE) | $20.00 Million | 0.00% | 0.50x | $16.86 Million |
| Zota Health Care LImited (ZOTA) | $181.02 Million | 23.54% | 1.12x | $435.89 Million |
About Blue Jet Healthcare Limited
Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance… Read more